DB-3Q / Direct Biologics - LARVOL DELTA

DB-3Q for the Treatment of Medically Refractory Crohn's Disease (clinicaltrials.gov) - P2 | N=36 | Recruiting | Sponsor: Direct Biologics, LLC | Not yet recruiting ➔ Recruiting

Enrollment open • Colon Cancer • Crohn's disease • Gastroenterology • Genetic Disorders • Immunology • Inflammatory Bowel Disease